#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16066	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2057	775.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	957	C	883	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	0	.	n	.	0	A20C	SNP	20	20	A	271	271	C	511	C,A	487,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	0	.	n	.	0	T695C	SNP	695	695	T	946	946	C	899	C,T	828,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1889	1889	G	922	G,A,T	863,5,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	934	C	867	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	964	A	903	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29590	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3526	836.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	889	C,T	815,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2372	folP	855	855	100.0	folP.l15.c4.ctg.1	1565	151.2	1	SNP	p	R229S	1	.	.	685	687	AGC	982	984	AGC	260;263;268	A,G;G;C	240,1;244;247	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3184	176.4	1	SNP	p	S91F	1	.	.	271	273	TTC	479	481	TTC	170;169;166	T;T;C	163;163;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3184	176.4	1	SNP	p	D95G	1	.	.	283	285	GGC	491	493	GGC	165;166;170	G;G;C	158;158;161	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3184	176.4	1	SNP	p	G95N	0	.	.	283	285	GGC	491	493	GGC	165;166;170	G;G;C	158;158;161	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1700	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1325	127.5	0	.	p	.	0	F184L	NONSYN	550	552	TTC	895	897	TTG	170;170;172	T;T;G,C	163;160;164,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1700	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1325	127.5	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	211;213;213	G;G;C	197;195;199	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	864	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	950	90.7	0	.	n	.	0	A197.	DEL	197	197	A	582	582	A	215	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5818	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3008	192.5	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	261;261;259	G;A;C	234;233;236	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5818	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3008	192.5	1	SNP	p	R87I	0	.	.	259	261	CGT	591	593	CGT	257;254;254	C;G,A;T	232;231,1;229	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5818	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3008	192.5	1	SNP	p	R87W	0	.	.	259	261	CGT	591	593	CGT	257;254;254	C;G,A;T	232;231,1;229	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5818	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3008	192.5	1	SNP	p	S87R	1	.	.	259	261	CGT	591	593	CGT	257;254;254	C;G,A;T	232;231,1;229	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5818	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3008	192.5	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	251;256;253	T;C;C	225;233;233	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4712	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2637	178.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1624	1626	GGC	206;209;207	G;G;C	193;195;192	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1333	1335	GCA	273;277;278	G;C;A	254;255;261	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1336	1338	ATC	277;272;274	A;T;C	257;252;254	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1348	1350	GTG	269;270;272	G;T;G	246;245;247	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1348	1350	GTG	269;270;272	G;T;G	246;245;247	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1852	1854	ACC	223;224;224	A;C;C,T	197;205;203,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1906	1908	GCG	199;200;197	G;C,G;G	172;163,1;169	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1906	1908	GCG	199;200;197	G;C,G;G	172;163,1;169	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2029	2031	AGC	217;211;210	A;G,A;C	190;188,1;190	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2038	2040	GGC	203;206;205	G;G;C	183;185;182	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4542	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2550	177.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2056	2058	CCG	179;180;178	C,G;C,G;G	120,13;125,2;126	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6222	ponA	2397	2397	99.92	ponA.l6.c4.ctg.1	3021	205.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1593	1595	CTG	229;226;225	C;T;G	205;207;205	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2304	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1742	131.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	535	535	C	154	C	136	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	396	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	439	44.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	363	365	ACG	117;113;110	A;C,T;G	97;93,1;93	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	396	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	439	44.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	405	407	CAA	47;44;41	C;A;A	44;43;40	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	396	porB1a	984	112	91.96	porB1a.l15.c30.ctg.2	439	44.3	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	411	413	TAC	32;33;31	T;A;C	31;32;31	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	372	374	GAA	272;270;268	G;A;A	256;256;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	783	785	TCA	238;239;241	T;C,T;A	223;221,1;224	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	912	914	GTC	224;224;224	G;T;C	211;210;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	924	926	TCT	218;214;218	T;C;T	209;206;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1242	1244	GCA	245;246;246	G;C;A	231;233;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	1	SNP	p	G120K	1	.	.	358	360	AAG	618	620	AAG	265;268;269	A;A;G	248;250;251	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	1	SNP	p	D121N	0	.	.	361	363	GAC	621	623	GAC	268;267;268	G;A;C	252;251;251	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3120	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1450	213.5	1	SNP	p	A121D	1	.	.	361	363	GAC	621	623	GAC	268;267;268	G;A;C	252;251;251	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11514	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4723	242.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1236	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1031	119.1	1	SNP	p	V57M	1	.	.	169	171	ATG	526	528	ATG	264;269;272	A;T;G	242;245;247	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
